Biocept Inc (BIOC)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Biocept Inc (BIOC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011918
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biocept Inc (Biocept) is a developer of diagnostic solutions. The company provides biopharmaceutical and clinical research, and molecular oncology laboratory services. It provides tests for various solid tumor cancers. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It offers patented methodology to isolate rare cells including circulating tumor cells, and cell-free circulating tumor DNA from the blood. The company also develops methodology to isolate cancer material including circulating tumor cells, and cell-free circulating tumor DNA. It serves medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers. Biocept is headquartered in San Diego, California, the US.

Biocept Inc (BIOC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biocept Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Biocept Inc, Medical Devices Deals, 2011 to YTD 2017 9
Biocept Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Biocept Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Biocept Raises Funds In Growth Equity Financing Round 11
Partnerships 12
Biocept Enters into Research Agreement with University of Minnesota 12
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 13
Biocept Enters into Partnership with Dana-Farber Cancer Institute 14
Equity Offering 15
Biocept Prices Public Offering of Shares for USD3.3 Million 15
Biocept Prices USD3.3 Million in Public Offering of Shares 17
Biocept Plans to Raise Funds through Private Placement of Shares 18
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 19
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 20
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 21
Biocept to Raise USD15 Million in Public Offering of Shares 22
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 23
Biocept Completes IPO For US$19 Million 25
Biocept Inc – Key Competitors 26
Biocept Inc – Key Employees 27
Biocept Inc – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Financial Announcements 29
Nov 09, 2017: Biocept Reports Third Quarter 2017 Financial Results 29
Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results 32
May 11, 2017: Biocept Reports First Quarter 2017 Financial Results 35
Mar 07, 2017: Biocept Reports Fourth Quarter and Full Year 2016 Financial Results 37
Nov 09, 2016: Biocept Reports 2016 Third Quarter Financial Results 39
Aug 02, 2016: Biocept Reports 2016 Second Quarter Financial Results 41
May 12, 2016: Biocept Reports 2016 First Quarter Financial Results 43
Mar 09, 2016: Biocept Reports 2015 Fourth Quarter and Full Year Financial Results 44
Corporate Communications 46
Oct 11, 2017: Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept’s Clinical Advisory Board 46
Jul 27, 2016: Biocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of Operations 47
Mar 23, 2016: Biocept’s Mark Foletta Honored with CFO Lifetime Achievement Award 48
Other Significant Developments 49
Mar 10, 2016: Progenetics to Distribute Biocept’s Liquid Biopsy Assays in Israel 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Biocept Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Biocept Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Biocept Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Biocept Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Biocept Inc, Medical Devices Deals, 2011 to YTD 2017 9
Biocept Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Biocept Raises Funds In Growth Equity Financing Round 11
Biocept Enters into Research Agreement with University of Minnesota 12
Biocept Enters into Research Agreement with Sarah Cannon Research Institute 13
Biocept Enters into Partnership with Dana-Farber Cancer Institute 14
Biocept Prices Public Offering of Shares for USD3.3 Million 15
Biocept Prices USD3.3 Million in Public Offering of Shares 17
Biocept Plans to Raise Funds through Private Placement of Shares 18
Biocept to Raise USD2.2 Million in Private Placement of Shares and Warrants 19
Biocept Prices Private Placement of Shares and Warrants for USD9.3 Million 20
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 21
Biocept to Raise USD15 Million in Public Offering of Shares 22
Biocept Raises USD10 Million in Public Offering of Shares and Warrants 23
Biocept Completes IPO For US$19 Million 25
Biocept Inc, Key Competitors 26
Biocept Inc, Key Employees 27

★海外企業調査レポート[Biocept Inc (BIOC)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Industrial Bank Of Korea:企業の戦略・SWOT・財務分析
    Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report Summary Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • PBF Energy Inc. (PBF)-石油・ガス分野:企業M&A・提携分析
    Summary PBF Energy Inc. (PBF Energy) is an independent oil refining company. It owns and operates crude oil refineries and related facilities in the US. Its refining assets include Delaware City refinery, Delaware; Paulsboro refinery, New Jersey; Chalmette refinery, Louisiana, Torrance, California a …
  • Carl Zeiss AG:企業の戦略的SWOT分析
    Carl Zeiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Medpace Inc (MEDP):企業の財務・戦略的SWOT分析
    Summary Medpace Inc (Medpace), a subsidiary of Medpace Holdings Inc is a contract research organization that develops research based drug and medical device. The organization provides services such as medical affairs, regulatory affairs and medical writing, clinical monitoring, clinical trial manage …
  • Fenner PLC (FENR):企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner) a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer components …
  • Winbond Electronics Corporation (2344):企業の財務・戦略的SWOT分析
    Winbond Electronics Corporation (2344) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Great Wall Motor Co Ltd:企業の戦略・SWOT・財務情報
    Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PSE Kinsale Energy Ltd:企業の戦略的SWOT分析
    PSE Kinsale Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NXP Semiconductors N.V.:企業の戦略・SWOT・財務情報
    NXP Semiconductors N.V. - Strategy, SWOT and Corporate Finance Report Summary NXP Semiconductors N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Tivoli A/S
    Tivoli A/S - Strategy, SWOT and Corporate Finance Report Summary Tivoli A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Kraton Polymers LLC:企業の戦略的SWOT分析
    Kraton Polymers LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Alterity Therapeutics Ltd (PBT):企業の財務・戦略的SWOT分析
    Summary Alterity Therapeutics Ltd (Alterity Therapeutics) formerly known as Prana Biotechnology Ltd, is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease, brain cancer and other major age-related degenerative disorders. It is developing …
  • SMART Technologies Inc.:企業の戦略的SWOT分析
    SMART Technologies Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Continental Grain Co:企業の戦略的SWOT分析
    Continental Grain Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Digital Locations Inc (CABN):企業の財務・戦略的SWOT分析
    Summary Digital Locations Inc (Digital Locations), is a provider of software solutions. It is a developer of cell tower sites for the 5G revolution. The company's 5G wireless networks provide applications include the Internet of things (IOT), self-driving cars, real-time hologram-based collaboration …
  • Club Mediterranee SA:戦略・SWOT・企業財務分析
    Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report Summary Club Mediterranee SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Intuitive Surgical Inc (ISRG):企業の財務・戦略的SWOT分析
    Intuitive Surgical Inc (ISRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Eagle Insurance Ltd:企業の戦略・SWOT・財務分析
    Eagle Insurance Ltd - Strategy, SWOT and Corporate Finance Report Summary Eagle Insurance Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MWH Global Inc:企業の戦略的SWOT分析
    MWH Global Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Bioverativ Inc (BIVV):医療機器:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆